Ovid Therapeutics Files 8-K on Security Holder Matters
Ticker: OVID · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1636651
| Field | Detail |
|---|---|
| Company | Ovid Therapeutics Inc. (OVID) |
| Form Type | 8-K |
| Filed Date | Jul 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, sec-filing
TL;DR
Ovid Therapeutics filed an 8-K for shareholder votes. Keep an eye on governance.
AI Summary
Ovid Therapeutics Inc. filed an 8-K on July 10, 2025, reporting on the submission of matters to a vote of security holders. The filing details events that occurred on or before July 9, 2025. The company is incorporated in Delaware and its principal executive offices are located in New York, NY.
Why It Matters
This filing indicates that Ovid Therapeutics is engaging in corporate governance activities requiring shareholder input, which could impact future strategic decisions or company direction.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding shareholder matters and does not appear to contain significant new financial or operational risks.
Key Players & Entities
- Ovid Therapeutics Inc. (company) — Registrant
- July 10, 2025 (date) — Filing Date
- July 9, 2025 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of Incorporation
- New York, New York (location) — Principal Executive Offices
FAQ
What specific matters were submitted for a vote of security holders?
The filing indicates the submission of matters to a vote of security holders but does not specify the exact nature of these matters within the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 9, 2025.
What is Ovid Therapeutics Inc.'s state of incorporation?
Ovid Therapeutics Inc. is incorporated in Delaware.
Where are Ovid Therapeutics Inc.'s principal executive offices located?
Ovid Therapeutics Inc.'s principal executive offices are located at 441 Ninth Avenue, 14th Floor, New York, New York.
What is the SEC file number for Ovid Therapeutics Inc.?
The SEC file number for Ovid Therapeutics Inc. is 001-38085.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding Ovid Therapeutics Inc. (OVID).